Federal Register / Vol. 70, No. 210 / Tuesday, November 1, 2005 / Notices 65909 

represented and a short description of the 

oral presentation. Only one representative of 

an organization may be allowed to present 

oral comments. Both printed and electronic 

copies are requested for the record. In 

addition, any interested person may file 

written comments with the committee. All 

written comments must be received by 

November 7, 2005 and should be sent via email to nsabb@od.nih.gov with ‘‘NSABB 

Public Comment’’ as the subject line or by 

regular mail to 6705 Rockledge Drive, Suite 

750, Bethesda, MD 20892, Attention Allison 

Chamberlain. The statement should include 

the name, address, telephone number and, 

when applicable, the business or professional 

affiliation of the interested person: 

Dated: October 20, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21661 Filed 10–31–05; 8:45 am] 

BILLING CODE 4140-01-M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel. RFA: 

CA06–502 ‘‘AIDS Malignancy Clinical Trials 

Consortium.’’

Date: November 30, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ramada Inn Rockville, 1775 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Joyce C. Pegues, PhD., 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd. 7149, 

Bethesda, MD 20892. 301/594–1286. 

peguesj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: October 20, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21646 Filed 10–31–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel 

Review of Research Project (R01) 

Applications 

Date: November 30, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Loews Annapolis Hotel, 126 West 

Street, Annapolis, MD 21401. 

Contact Person: Katherine M. Malinda, 

PhD, Scientific Review Administrator, 

Review Branch, Division of Extramural 

Affairs, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6701 

Rockledge Drive, Room 7198, Bethesda, MD 

20892, 301/435–0297. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel 

Review of Research Project (RO1) 

Applications 

Date: November 30, 2005. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892, (Telephone Conference Call). 

Contact Person: Patricia A. Haggerty, PhD, 

Scientific Review Administrator, National 

Heart, Lung, and Blood Institute/NIH, 

Clinical Studies & Training Studies Rev. 

Grp., Division of Extramural Affairs/Section 

Chief, 6701 Rockledge Drive, Room 7194, 

Bethesda, MD 20892, 301/435–0288. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 20, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–21656 Filed 10–31–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the Sleep 

Disorders Research Advisory Board. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting: 

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: December 6, 2005. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To discuss sleep research and 

education priorities and programs. 

Place: National Institutes of Health, 

Natcher Building, Conference Room D, 

Bethesda, MD 20892. 

Contact Person: Carl E Hunt, MD, Director, 

National Center on Sleep Disorders Research, 

National Heart, Lung, and Blood Institute, 

National Institutes of Health, 6705 Rockledge 

Drive, Room 6022, Bethesda, MD 20892, 301/ 

435–0199. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. This statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-governmental 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nhlbi.nih.gov/meetings/index.htm, 

where an agenda and any additional